超级大洗牌!跨国药企中国市场最新排名

健识局
Feb 16

1月份,跨国药企基本都披露了2025年业绩。强生和罗氏分别以942亿美元、744.28亿美元稳居榜单前两位。礼来则以45%的增幅,营收达651.79亿美元成功反超默沙东,排名第三。默沙东、辉瑞、艾伯维紧随其后,位列四至六名。2月10日,随着阿斯利康交出全年营收587.39亿美元的答卷,锁定第七名,2025年跨国药企收入前十名新鲜出炉。这只是跨国药企们在全球的收入。具体到中国区,排名就有了很大的变化...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10